Chao Feng Hao

Director of Finance/CFO en Jiangsu Cowin Biotech Co., Ltd. .

Fortuna: 24 739 $ al 31/03/2024

42 años

20 relaciones

Health Technology

Consumer Services

Producer Manufacturing

Perfil

Chao Feng Hao is currently the Finance Director & Deputy General Manager at Jiangsu Cowin Biotech Co., Ltd.
Prior to this, he worked as the Chief Financial Officer at Shanghai Shyndec Pharmaceutical Co., Ltd.
and WPG (Shanghai) Smart Water Public Co., Ltd.
Mr. Hao completed his undergraduate degree at Zhengzhou Institute of Aeronautical Industry Management.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. CLASS A 0.00%	14/04/2023	20 000 ( 0.00% )	24 739 $	31/03/2024

Cargos activos de Chao Feng Hao

Empresas	Cargo	Inicio
Jiangsu Cowin Biotech Co., Ltd. Jiangsu Cowin Biotech Co., Ltd. BiotechnologyHealth Technology Jiangsu Cowin Biotech Co., Ltd. engages in the provision of molecular testing services as well as the research and development of molecular testing products. Its products include raw materials for molecular detection enzymes, nucleic acid preservation reagents, nucleic acid extraction and purification reagents, and molecular diagnostic kits. The company was founded by Chun Xiang Wang on September 3, 2010 and is headquartered in Taizhou, China.	Director of Finance/CFO	27/10/2023